Administrative Core

行政核心

基本信息

  • 批准号:
    10380820
  • 负责人:
  • 金额:
    $ 18.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-04 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

ADMINISTRATIVE CORE PROJECT SUMMARY The Administrative Core of the “Immunobiology and Immune Therapy for Merkel cell carcinoma” P01 provides overall direction, coordination of the Scientific Advisory Board meetings, as well as administrative, regulatory and fiscal oversight to the three Projects and the three Shared Resource Cores (Biostatistics & Bioinformatics, Immunophenotyping, and Specimen & Data). The Administrative Core will provide an effective organizational structure to expedite research and promote communication between Program Project components and investigators and the scientific and patient communities. The Administrative Core is responsible for strategic planning, as well as effective organizational structure among the performance sites (Fred Hutchinson Cancer Research Center, University of Washington, and Seattle Cancer Care Alliance). The Administrative Core is responsible for research effort coordination and allocation of NIH funds. This Core will also manage fiscal components of the Program Project including reallocation of funds to optimize overall function, and resolution of potential conflicts in a fair and equitable manner to maximize progress of the Program. The Administrative Core is responsible for communication including dissemination of information relevant to the Program via email, GoToMeeting teleconferences, as well as in-person meetings. In addition, The Core will provide strategic outreach to the patient, physician, and scientific communities through maintenance of the merkelcell.org website (which reaches 100,000 unique users each year), coordination with our MCC patient advocates, and organization of the MCC Multicenter Interest Group annual meeting. The mission of this Core is to ensure regulatory and administrative compliance including reporting to the Scientific Advisory Boards and NIH as well as to support and sustain optimal efficiency of the Projects and Cores of the Program.
管理的核心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL NGHIEM其他文献

PAUL NGHIEM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL NGHIEM', 18)}}的其他基金

Immunobiology and Immune Therapy for Merkel Cell Carcinoma
默克尔细胞癌的免疫生物学和免疫治疗
  • 批准号:
    9906874
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
项目 2:描述和克服对 PD-1 阻断疗法无反应的问题
  • 批准号:
    10380818
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Core 1: Specimen and Data Core
核心 1:样本和数据核心
  • 批准号:
    10629194
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Core 1: Specimen and Data Core
核心 1:样本和数据核心
  • 批准号:
    10380821
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10629193
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
项目 2:描述和克服对 PD-1 阻断疗法无反应的问题
  • 批准号:
    10629191
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Immunobiology and Immune Therapyfor Merkel Cell Carcinoma
默克尔细胞癌的免疫生物学和免疫治疗
  • 批准号:
    10629189
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Immunobiology and Immune Therapyfor Merkel Cell Carcinoma
默克尔细胞癌的免疫生物学和免疫治疗
  • 批准号:
    10380816
  • 财政年份:
    2019
  • 资助金额:
    $ 18.77万
  • 项目类别:
Mechanisms of UV-induced DNA damage responses and carcinogenesis in skin
紫外线诱导的皮肤 DNA 损伤反应和致癌机制
  • 批准号:
    9038985
  • 财政年份:
    2015
  • 资助金额:
    $ 18.77万
  • 项目类别:
Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma
默克尔细胞癌改进治疗的发病机制和预后研究
  • 批准号:
    8699412
  • 财政年份:
    2014
  • 资助金额:
    $ 18.77万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 18.77万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 18.77万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 18.77万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 18.77万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 18.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了